Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Stacey Bagby

Concepts (212)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Xenograft Model Antitumor Assays
23
2024
864
1.180
Why?
Colorectal Neoplasms
12
2024
792
1.050
Why?
Melanoma
9
2024
757
0.860
Why?
Antineoplastic Agents
13
2020
2129
0.770
Why?
Mice, Nude
16
2024
692
0.600
Why?
Proto-Oncogene Proteins B-raf
4
2021
226
0.520
Why?
Protein Kinase Inhibitors
7
2020
916
0.510
Why?
Drug Discovery
1
2016
141
0.480
Why?
Azepines
4
2024
90
0.480
Why?
Cell Line, Tumor
21
2024
3399
0.470
Why?
Heterografts
4
2021
138
0.460
Why?
Triple Negative Breast Neoplasms
3
2024
201
0.450
Why?
Pyrimidines
4
2020
470
0.450
Why?
Piperazines
4
2021
350
0.440
Why?
Adrenocortical Carcinoma
3
2020
65
0.430
Why?
Gene Expression Regulation, Neoplastic
8
2024
1396
0.400
Why?
Carcinoma, Pancreatic Ductal
3
2024
285
0.400
Why?
Drug Resistance, Neoplasm
6
2024
800
0.380
Why?
Oncogene Proteins, Fusion
3
2018
214
0.360
Why?
Quinoxalines
3
2020
66
0.360
Why?
Histone Deacetylase Inhibitors
2
2024
210
0.360
Why?
Dasatinib
2
2024
54
0.360
Why?
Mice
26
2024
17731
0.330
Why?
Cell Proliferation
12
2024
2473
0.320
Why?
Disease Models, Animal
7
2022
4279
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1683
0.320
Why?
Neoplasms
5
2022
2644
0.300
Why?
Pancreatic Neoplasms
3
2024
931
0.290
Why?
Adrenal Cortex Neoplasms
2
2020
63
0.290
Why?
Tumor Microenvironment
3
2022
671
0.280
Why?
Apoptosis
13
2024
2548
0.270
Why?
Antibodies, Monoclonal, Humanized
2
2024
804
0.260
Why?
Animals
29
2024
36768
0.260
Why?
Anilides
2
2018
73
0.250
Why?
Signal Transduction
10
2024
5065
0.250
Why?
Pyridines
3
2021
505
0.230
Why?
Gene Regulatory Networks
2
2024
308
0.230
Why?
Bevacizumab
1
2024
136
0.210
Why?
Endogenous Retroviruses
1
2024
36
0.210
Why?
Proto-Oncogene Proteins
2
2018
646
0.210
Why?
Mucous Membrane
1
2024
125
0.210
Why?
Benzimidazoles
1
2024
168
0.210
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2020
40
0.210
Why?
Deoxycytidine
2
2024
175
0.210
Why?
Camptothecin
3
2022
114
0.200
Why?
Immunotherapy
3
2022
640
0.190
Why?
Wnt Signaling Pathway
2
2024
192
0.180
Why?
Lymphocytes, Tumor-Infiltrating
2
2020
209
0.180
Why?
Fluorouracil
1
2022
210
0.180
Why?
beta Catenin
2
2020
251
0.180
Why?
Cyclin-Dependent Kinase 4
1
2021
47
0.180
Why?
MAP Kinase Kinase 1
1
2021
75
0.180
Why?
Cyclin-Dependent Kinase 6
1
2021
42
0.180
Why?
Transplantation, Heterologous
2
2022
195
0.170
Why?
Momordica charantia
1
2020
15
0.170
Why?
Aurora Kinase A
2
2020
56
0.170
Why?
Benzoxazoles
1
2020
19
0.170
Why?
Humans
38
2024
136783
0.160
Why?
Neoplasms, Experimental
2
2019
176
0.160
Why?
Immune System
1
2021
177
0.160
Why?
Biomarkers, Tumor
5
2021
1274
0.160
Why?
Aniline Compounds
1
2020
102
0.160
Why?
eIF-2 Kinase
1
2019
31
0.160
Why?
Pyrimidinones
2
2021
113
0.160
Why?
Mitogen-Activated Protein Kinase Kinases
1
2019
134
0.160
Why?
c-Mer Tyrosine Kinase
1
2018
45
0.150
Why?
Tumor Cells, Cultured
4
2021
953
0.150
Why?
CDC2 Protein Kinase
1
2018
31
0.150
Why?
Pyridones
2
2021
168
0.150
Why?
Plant Extracts
1
2020
200
0.150
Why?
SOXB1 Transcription Factors
1
2018
61
0.140
Why?
Septins
1
2018
43
0.140
Why?
Adrenal Cortex
1
2018
29
0.140
Why?
Oncogene Proteins v-abl
1
2017
5
0.140
Why?
Drug Synergism
2
2018
378
0.140
Why?
Programmed Cell Death 1 Receptor
1
2020
250
0.140
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
35
0.140
Why?
Armadillo Domain Proteins
1
2017
6
0.130
Why?
src-Family Kinases
1
2017
92
0.130
Why?
Proto-Oncogene Proteins c-ret
1
2017
31
0.130
Why?
Ubiquitin-Activating Enzymes
1
2016
17
0.130
Why?
Neoplasm Metastasis
2
2016
654
0.130
Why?
Cyclopentanes
1
2016
20
0.130
Why?
Adenine
1
2018
267
0.130
Why?
Skin Neoplasms
1
2024
852
0.130
Why?
Corynebacterium
1
2017
49
0.130
Why?
Sulfonamides
1
2020
512
0.130
Why?
Corynebacterium Infections
1
2017
41
0.130
Why?
Cell Transformation, Neoplastic
1
2018
326
0.130
Why?
Tankyrases
1
2016
15
0.130
Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.120
Why?
Autophagy
1
2018
281
0.120
Why?
Female
22
2024
72840
0.120
Why?
TOR Serine-Threonine Kinases
2
2018
412
0.120
Why?
MAP Kinase Kinase Kinases
1
2015
73
0.120
Why?
Receptor, Notch1
1
2015
64
0.120
Why?
Aldehyde Dehydrogenase
1
2016
100
0.120
Why?
Pyrazoles
1
2018
423
0.120
Why?
Gene Dosage
1
2015
144
0.110
Why?
Phosphorylation
4
2019
1756
0.110
Why?
Gene Expression Regulation
1
2024
2603
0.110
Why?
DNA Copy Number Variations
1
2015
182
0.110
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2014
86
0.110
Why?
Proto-Oncogene Proteins c-met
1
2014
75
0.110
Why?
Cell Cycle Proteins
1
2018
611
0.110
Why?
Protein-Tyrosine Kinases
1
2017
434
0.100
Why?
Mitogen-Activated Protein Kinases
1
2014
313
0.100
Why?
Enzyme Inhibitors
1
2016
838
0.100
Why?
Neoplasm Invasiveness
3
2020
507
0.100
Why?
Gene Expression Profiling
3
2024
1768
0.090
Why?
Cell Survival
3
2019
1117
0.090
Why?
Mutation
2
2018
3953
0.080
Why?
Carcinogenesis
2
2024
217
0.080
Why?
Cell Cycle
3
2018
601
0.080
Why?
Mice, Inbred NOD
2
2022
601
0.080
Why?
Phosphatidylinositol 3-Kinases
3
2018
365
0.080
Why?
RNA, Small Interfering
2
2024
621
0.080
Why?
Breast Neoplasms
1
2021
2239
0.080
Why?
Mice, Inbred BALB C
2
2020
1267
0.070
Why?
Tumor Suppressor Protein p53
2
2024
530
0.060
Why?
HCT116 Cells
2
2018
80
0.060
Why?
Aged
6
2024
23729
0.060
Why?
Middle Aged
7
2024
33200
0.060
Why?
Tumor Burden
2
2018
309
0.060
Why?
Angiogenesis Inhibitors
2
2018
226
0.060
Why?
Neovascularization, Pathologic
2
2018
301
0.060
Why?
Immunoblotting
2
2015
307
0.060
Why?
Proto-Oncogene Proteins c-akt
2
2018
436
0.050
Why?
Microsatellite Repeats
1
2024
167
0.050
Why?
Triazoles
1
2024
147
0.050
Why?
Organoids
1
2024
111
0.050
Why?
Enhancer Elements, Genetic
1
2024
190
0.050
Why?
Paclitaxel
1
2024
227
0.050
Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
66
0.050
Why?
Histone Deacetylase 1
1
2022
25
0.050
Why?
Doxorubicin
1
2024
365
0.050
Why?
Molecular Targeted Therapy
1
2024
413
0.040
Why?
Chimerism
1
2021
31
0.040
Why?
Acetylation
1
2022
248
0.040
Why?
Male
7
2024
67361
0.040
Why?
Lymphocyte Subsets
1
2021
87
0.040
Why?
Aminopyridines
1
2021
99
0.040
Why?
Lymphoid Tissue
1
2021
75
0.040
Why?
Membrane Proteins
2
2018
1162
0.040
Why?
Histone Deacetylases
1
2022
214
0.040
Why?
Pyrroles
1
2021
211
0.040
Why?
Mice, SCID
1
2021
367
0.040
Why?
Adult
5
2024
37616
0.040
Why?
Antimetabolites, Antineoplastic
1
2020
94
0.040
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
Why?
Indolizines
1
2019
4
0.040
Why?
Forkhead Box Protein M1
1
2019
7
0.040
Why?
Maximum Tolerated Dose
1
2020
198
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
125
0.040
Why?
Cell Cycle Checkpoints
1
2019
98
0.040
Why?
Prognosis
2
2019
4018
0.040
Why?
Genomics
1
2024
790
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
Why?
Azetidines
1
2018
43
0.040
Why?
4-Aminobenzoic Acid
1
2018
7
0.040
Why?
GTP Phosphohydrolases
1
2018
92
0.040
Why?
HT29 Cells
1
2018
40
0.040
Why?
Aldosterone
1
2018
44
0.040
Why?
Transcription, Genetic
1
2024
1453
0.040
Why?
Drug Therapy, Combination
1
2020
1059
0.030
Why?
Antineoplastic Agents, Immunological
1
2020
189
0.030
Why?
RNA
1
2024
924
0.030
Why?
Piperidines
1
2018
205
0.030
Why?
Protein Transport
1
2018
442
0.030
Why?
Germ-Line Mutation
1
2018
172
0.030
Why?
Positron-Emission Tomography
1
2018
295
0.030
Why?
Inhibitory Concentration 50
1
2016
90
0.030
Why?
Histones
1
2022
635
0.030
Why?
Axin Protein
1
2016
19
0.030
Why?
Ubiquitination
1
2016
102
0.030
Why?
Algorithms
1
2024
1686
0.030
Why?
Aldehyde Dehydrogenase, Mitochondrial
1
2016
23
0.030
Why?
Cetuximab
1
2016
95
0.030
Why?
Tissue Array Analysis
1
2016
57
0.030
Why?
Protein Isoforms
1
2017
400
0.030
Why?
Neoplasm Transplantation
1
2016
256
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
121
0.030
Why?
Gene Rearrangement
1
2017
149
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
193
0.030
Why?
Sequence Analysis, RNA
1
2018
451
0.030
Why?
Serrate-Jagged Proteins
1
2015
27
0.030
Why?
Jagged-1 Protein
1
2015
23
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2021
615
0.030
Why?
Gene Duplication
1
2015
68
0.030
Why?
Diphenylamine
1
2014
9
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
267
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
284
0.030
Why?
Neoplastic Stem Cells
1
2018
397
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
95
0.030
Why?
Calcium-Binding Proteins
1
2015
218
0.030
Why?
RNA Interference
1
2016
464
0.030
Why?
Mice, Knockout
1
2021
2999
0.030
Why?
Benzamides
1
2014
217
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2015
379
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
765
0.030
Why?
Transfection
1
2016
945
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2017
535
0.030
Why?
Up-Regulation
1
2016
843
0.020
Why?
Phenotype
1
2021
3199
0.020
Why?
Protein Binding
1
2018
2223
0.020
Why?
Immunohistochemistry
1
2016
1731
0.020
Why?
Models, Biological
1
2018
1769
0.020
Why?
Treatment Outcome
1
2024
10764
0.020
Why?
Transcriptome
1
2015
971
0.020
Why?
Antibodies, Monoclonal
1
2015
1428
0.020
Why?
Magnetic Resonance Imaging
1
2018
3566
0.020
Why?
Aged, 80 and over
1
2017
7569
0.010
Why?
Bagby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)